NASDAQ · RCEL
Avita Medical, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for RCEL: Nov 05, 2026
Avita Medical, Inc. Common Stock is expected to report earnings on 11/05/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. The reported EPS for the same quarter last year was $-0.46.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Fintel · Zacks · MarketBeat- RTTNews · Oct 12, 5:40 AM EDTBiotech Stocks At 52-Week Highs – HUM +11%, MRNA +14%, PBYI, ABBV, RCEL(RTTNews) – The following biotech stocks reached a 52-week high on October 9, 2026, driven by catalysts such as achieving new regulatory milestones.
- RTTNews · Oct 5, 4:26 AM EDTBiotech Stocks At 52-Week Highs – CDNA, RCEL, AZTA, HNGE(RTTNews) – The following biotech stocks reached a 52-week high on October 2, 2026, driven by key catalysts such as encouraging quarterly reports.
- Fintel · Sep 15, 10:51 AM EDTAVITA Medical Consensus Price Target Increased by 12.12% to $12.58The average one-year price target for AVITA Medical (NASDAQCM:RCEL) has been revised to $12.58 / share, up 12.12% from the prior estimate of $11.22 dated August 25, 2026. These figures represent aggregate analyst targets and do not constitute a recommendation by Fintel.The latest
- RTTNews · Sep 3, 10:47 PM EDT6 Biotech Stocks In Focus: Modular Medical, Galmed, Pro-Dex, Connect Biopharma & More(RTTNews) – Today's after-hours gainers include Modular Medical, following FDA clearance for a series of software enhancements to its Pivot tubeless patch pump; Galmed Pharmaceuticals, after shareholders approved all five proposals presented at its annual general meeting; and Pro
- Zacks · Aug 31, 12:00 PM EDTAll You Need to Know About Avita Medical (RCEL) Rating Upgrade to BuyAvita Medical (RCEL) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- Zacks · Aug 24, 12:00 PM EDTAvita Medical Inc. (RCEL) is a Great Momentum Stock: Should You Buy?Does Avita Medical Inc. (RCEL) have what it takes to be a top stock pick for momentum investors? Let's find out.
- MarketBeat · Aug 19, 8:02 AM EDTAvita Medical PermeaDerm Study Shows 70% Cost Reduction vs. AllograftAvita Medical (NASDAQ:RCEL) presented results from its PermeaDerm-I study, a randomized controlled trial evaluating PermeaDerm as temporary wound coverage following excision and before split-thickness skin grafting, compared with cadaveric allograft. During a key opinion leader
- RTTNews · Aug 18, 10:41 AM EDTAVITA Medical Reports 70% Cost Advantage For PermeaDerm With Comparable Allograft Outcomes(RTTNews) – AVITA Medical, Inc. (RCEL, AVH) announced positive results from its multicenter, randomized controlled PermeaDerm-I study, showing that its biosynthetic wound matrix delivered clinically comparable outcomes to cadaveric allograft while reducing treatment costs by 70%.
- MarketBeat · Aug 16, 6:01 PM EDTAvita Medical Raises 2026 Revenue Outlook as Q2 Sales Climb 18%Avita Medical (NASDAQ:RCEL) reported second-quarter 2026 revenue of $21.7 million, up 13% sequentially from $19.3 million in the first quarter and 18% from $18.4 million a year earlier, as the wound-care company cited growth across its product portfolio and in U.S. and internatio
- MarketBeat · Aug 16, 5:01 PM EDTAvita Medical Targets Q4 2025 Cash Flow Breakeven as Revenue Growth BuildsAvita Medical (NASDAQ:RCEL) expects continued sequential revenue growth and aims to reach cash flow breakeven in the fourth quarter of 2025, President and CEO Cary Vance said at the Canaccord 46th Annual Boston Growth Conference. Vance, who has been CEO for about 10 months after
- The Motley Fool · Aug 13, 6:15 PM EDTAVITA Medical (RCEL) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 7, 6:03 AM EDTAvita Medical Q2 Earnings Call HighlightsAvita Medical (NASDAQ:RCEL) reported second-quarter 2026 revenue of $21.7 million, up 18% from a year earlier and 13% sequentially, as growth in its RECELL wound-care product and newer portfolio offerings supported results. President and Chief Executive Officer Cary Vance said t
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Avita Medical, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.